Abcellera Biologics shares owned by EPIQ Capital Group
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by EPIQ Capital Group
from 13F filings
Historical chart of EPIQ Capital Group investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by EPIQ Capital Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Abcellera Biologics by EPIQ Capital Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $224k | 86k | 2.60 |
2024-06-30 | $255k | 86k | 2.96 |
2024-03-31 | $391k | 86k | 4.53 |
2023-12-31 | $493k | 86k | 5.71 |
2023-09-30 | $397k | 86k | 4.60 |
2023-06-30 | $557k | 86k | 6.46 |
2023-03-31 | $651k | 86k | 7.54 |
2022-12-31 | $874k | 86k | 10.13 |
2022-09-30 | $853k | 86k | 9.89 |
2022-06-30 | $1.2M | 110k | 10.65 |
2022-03-31 | $889k | 91k | 9.75 |
2021-12-31 | $1.3M | 92k | 14.30 |
2021-09-30 | $2.9M | 143k | 20.04 |